These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Integrated analysis of genetic and epigenetic alterations in cancer. Toyota M; Suzuki H; Yamamoto E; Yamano H; Imai K; Shinomura Y Epigenomics; 2009 Dec; 1(2):291-9. PubMed ID: 22122704 [TBL] [Abstract][Full Text] [Related]
4. DNA methylation aberrancies delineate clinically distinct subsets of colorectal cancer and provide novel targets for epigenetic therapies. Weisenberger DJ; Liang G; Lenz HJ Oncogene; 2018 Feb; 37(5):566-577. PubMed ID: 28991233 [TBL] [Abstract][Full Text] [Related]
5. A novel DNA methylation panel accurately detects colorectal cancer independently of molecular pathway. Freitas M; Ferreira F; Carvalho S; Silva F; Lopes P; Antunes L; Salta S; Diniz F; Santos LL; Videira JF; Henrique R; Jerónimo C J Transl Med; 2018 Feb; 16(1):45. PubMed ID: 29486770 [TBL] [Abstract][Full Text] [Related]
6. Colorectal cancer: epigenetic alterations and their clinical implications. Puccini A; Berger MD; Naseem M; Tokunaga R; Battaglin F; Cao S; Hanna DL; McSkane M; Soni S; Zhang W; Lenz HJ Biochim Biophys Acta Rev Cancer; 2017 Dec; 1868(2):439-448. PubMed ID: 28939182 [TBL] [Abstract][Full Text] [Related]
7. Characterization of Chilean patients with sporadic colorectal cancer according to the three main carcinogenic pathways: Microsatellite instability, CpG island methylator phenotype and Chromosomal instability. Wielandt AM; Hurtado C; Moreno C M; Villarroel C; Castro M; Estay M; Simian D; Martinez M; Vial MT; Kronberg U; López-Köstner F Tumour Biol; 2020 Jul; 42(7):1010428320938492. PubMed ID: 32635826 [TBL] [Abstract][Full Text] [Related]
8. Clinical and molecular features of young-onset colorectal cancer. Ballester V; Rashtak S; Boardman L World J Gastroenterol; 2016 Feb; 22(5):1736-44. PubMed ID: 26855533 [TBL] [Abstract][Full Text] [Related]
9. The CpG island methylator phenotype and chromosomal instability are inversely correlated in sporadic colorectal cancer. Goel A; Nagasaka T; Arnold CN; Inoue T; Hamilton C; Niedzwiecki D; Compton C; Mayer RJ; Goldberg R; Bertagnolli MM; Boland CR Gastroenterology; 2007 Jan; 132(1):127-38. PubMed ID: 17087942 [TBL] [Abstract][Full Text] [Related]
10. Molecular dissection of premalignant colorectal lesions reveals early onset of the CpG island methylator phenotype. Yamamoto E; Suzuki H; Yamano HO; Maruyama R; Nojima M; Kamimae S; Sawada T; Ashida M; Yoshikawa K; Kimura T; Takagi R; Harada T; Suzuki R; Sato A; Kai M; Sasaki Y; Tokino T; Sugai T; Imai K; Shinomura Y; Toyota M Am J Pathol; 2012 Nov; 181(5):1847-61. PubMed ID: 22995252 [TBL] [Abstract][Full Text] [Related]
12. Molecular biomarkers in colorectal carcinoma. Puerta-García E; Cañadas-Garre M; Calleja-Hernández MÁ Pharmacogenomics; 2015; 16(10):1189-222. PubMed ID: 26237292 [TBL] [Abstract][Full Text] [Related]
13. Clinicopathologic and molecular characteristics of synchronous colorectal cancers: heterogeneity of clinical outcome depending on microsatellite instability status of individual tumors. Bae JM; Cho NY; Kim TY; Kang GH Dis Colon Rectum; 2012 Feb; 55(2):181-90. PubMed ID: 22228162 [TBL] [Abstract][Full Text] [Related]
14. DNA methylation markers in colorectal cancer. Kim MS; Lee J; Sidransky D Cancer Metastasis Rev; 2010 Mar; 29(1):181-206. PubMed ID: 20135198 [TBL] [Abstract][Full Text] [Related]
16. A novel classification of colorectal tumors based on microsatellite instability, the CpG island methylator phenotype and chromosomal instability: implications for prognosis. Simons CC; Hughes LA; Smits KM; Khalid-de Bakker CA; de Bruïne AP; Carvalho B; Meijer GA; Schouten LJ; van den Brandt PA; Weijenberg MP; van Engeland M Ann Oncol; 2013 Aug; 24(8):2048-56. PubMed ID: 23532114 [TBL] [Abstract][Full Text] [Related]